Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

E-ISSN： 1873-4316|13|1|210-217

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.1, 2012-01, pp. : 210-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Silymarin in the Treatment of Liver Diseases

By Saller R.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2035-2063

Adis International

Access to resources Recommend Favorite

Recent advances in herbal medicine for treatment of liver diseases

By Ghosh Nilanjan Ghosh Rituparna Mandal Vivekananda Mandal Subhash C.

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 9, 2011-09 ,pp. : 970-988

Informa Healthcare

Access to resources Recommend Favorite

Apoptotic Signaling Pathways as a Target for the Treatment of Liver Diseases

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1485-1493

Bentham Science Publishers

Access to resources Recommend Favorite

RNA Interference as a Therapeutic Strategy for the Treatment of Liver Diseases

Current Pharmaceutical Design, Vol. 21, Iss. 31, 2015-09 ,pp. : 4574-13

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 709-740

Bentham Science Publishers

Access to resources Recommend Favorite